Explore
COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
0 Ungluers have
Faved this Work
Login to Fave
COVID-19 is the most prominent and rapidly evolving public health concern in the world currently. The gastrointestinal manifestations of COVID-19 are increasingly being recognized. SARS-CoV-2 infection has been associated with the occurrence of nausea, vomiting, and diarrhea. SARS-CoV-2 has also been causing pancreatic and hepatic injury. Emerging data have shown that COVID-19 patients continue to shed the virus into their stools, even when patients test negative for COVID-19 in pulmonary secretions. However, the epidemiology, pathogenesis, and treatment of SARS-CoV-2-related gastrointestinal manifestations are poorly understood. The pandemic has also had a significant impact on gastroenterologists, endoscopists, and other ancillary staff. Moreover, in the past, systematic respiratory virus syndrome (SARS) was shown to be transmitted by endoscopes, which is a big concern with COVID-19, as it shares many pathological features with SARS. The deferral of elective endoscopic procedures has negatively affected gastroenterologists. This Special Issue focuses on the current situation of this pandemic. It aims to provide insight into the gastrointestinal manifestations of COVID-19 and its effects on endoscopic procedures. I believe that this issue will be beneficial not only for gastroenterologists but also other healthcare workers around the world to recognize the often-ignored clinical gastrointestinal manifestations of COVID-19.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 38 times via unglue.it ebook links.
- 38 - pdf (CC BY) at Unglue.it.
Keywords
- abdominal pain
- ACE2 dysregulation
- acute mesenteric ischemia
- Anxiety
- clinical course
- clinical manifestations
- COVID-19
- Cytokines
- delivery of healthcare
- Depression
- dyspnea
- Endoscopy
- endothelitis
- enteric infection
- Gastroenterology
- gastrointestinal disorders
- gastrointestinal manifestations
- gut dysbiosis
- Gut Microbiota
- Hepatology
- hospitalized patients
- hypercoagulability
- inflammatory bowel disease
- intestinal inflammation
- Liver
- Liver disease
- medication adherence
- medicine
- microbiota
- Mortality
- non-alcoholic steatohepatitis
- outcomes
- Pandemic
- Risk factors
- SARS-CoV-2
- SARS-CoV-2 infection
- severity of COVID-19
- thromboemboembolism
- transient elastography
- upper gastrointestinal bleeding
Links
DOI: 10.3390/books978-3-0365-6090-8Editions